Child-Pugh B级或C级肝病增加接受择期全关节置换术的丙型肝炎患者早期死亡风险,且与治疗状态无关
该回顾性研究在三个三级学术医疗中心纳入2005年1月至2019年12月间接受初次择期全关节置换术的丙型肝炎病毒(HCV)患者169例,中位随访53±29个月。多变量回归显示Child-Pugh B级或C级是早期(2年内)死亡的唯一独立相关因素(调整OR 29,95%CI 5-174,p<0.001),其早期死亡率64%(7/11)显著高于A级的6%(9/158,p<0.001)。作者建议外科医生应尽可能避免对Child-Pugh B级或C级患者行此类大型择期手术。
要点
- Child-Pugh B级或C级是HCV患者择期全关节置换术后2年内死亡的唯一独立相关因素(调整OR 29,95%CI 5-174,p<0.001)。
- Child-Pugh B级或C级患者早期死亡率为64%(7/11),显著高于A级患者的6%(9/158)(p<0.001)。
- 作者建议外科医生应尽可能避免对Child-Pugh B级或C级患者行大型择期关节置换手术。
核心结论
- Child-Pugh B级或C级是HCV患者接受择期全关节置换术后早期(2年内)死亡的唯一独立相关因素(调整OR 29,95%CI 5-174,p<0.001),且与肝功能、肝硬化、年龄、终末期肝病模型评分、HCV治疗及病毒载量状态无关。
研究设计与样本
- 回顾性研究,在三个三级学术医疗中心纳入2005年1月至2019年12月间接受初次择期全关节置换术的HCV患者,排除翻修及同期双侧初次置换者。
- 初始符合条件226例,排除失访或数据不完整者57例(25%),最终分析169例(75%),平均随访53±29个月。
- 比较早期死亡组(16例)与存活组(153例)的合并症、HCV及肝脏特征、HCV治疗及术后内科和外科并发症,并对单变量分析中p<0.05的显著变量进行多变量回归分析。
主要发现
- 早期死亡组更可能具有更高的Child-Pugh分级以及外周血管疾病、终末期肾病、心力衰竭和慢性阻塞性肺疾病等合并症。
- 两组90天及1年内科并发症风险(包括心肌梗死、卒中、肺栓塞)及因假体周围感染和机械失败再手术风险相似。
- 校正单变量分析中显著的变量(外周血管疾病、终末期肾病、心力衰竭、慢性阻塞性肺疾病及肝纤维化分期)后,Child-Pugh B级或C级是早期死亡的唯一独立相关因素(调整OR 29,95%CI 5-174,p<0.001)。
- Child-Pugh B级或C级患者早期死亡风险为64%(7/11),Child-Pugh A级患者为6%(9/158)(p<0.001)。
关键数值与推荐
- Child-Pugh B级或C级:早期死亡率64%(7/11);Child-Pugh A级:早期死亡率6%(9/158);p<0.001。
- Child-Pugh B级或C级与早期死亡独立相关:调整OR 29(95%CI 5-174),p<0.001。
临床怎么用
- 作者建议外科医生应尽可能避免对Child-Pugh B级或C级患者行大型择期关节置换手术。
- 对于关节炎症状和疼痛难以忍受的患者,外科医生需要明确告知死亡风险显著升高。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients with hepatitis C virus (HCV) undergoing primary elective total joint arthroplasty (TJA) are at increased risk of postoperative complications. Patients with chronic liver disease and cirrhosis, specifically Child-Pugh Class B and C, who are undergoing general surgery have high 2-year mortality risks, approaching 60% to 80%. However, the role of Child-Pugh and Model for End-Stage Liver Disease classifications of liver status in predicting survivorship among patients with HCV undergoing elective arthroplasty has not been elucidated. QUESTION/PURPOSE: What factors are independently associated with early mortality (< 2 years) in patients with HCV undergoing arthroplasty? METHODS: We performed a retrospective study at three tertiary academic medical centers and identified patients with HCV undergoing primary elective TJA between January 2005 and December 2019. Patients who underwent revision TJA and simultaneous primary TJA were excluded. A total of 226 patients were eligible for inclusion in the study. A further 25% (57) were excluded because they were lost to follow-up before the minimum study requirement of 2 years of follow-up or had incomplete datasets. After the inclusion and exclusion criteria were applied, the final cohort consisted of 75% (169 of 226) of the initial patient population eligible for analysis. The mean follow-up duration was 53 ± 29 months. We compared confounding variables for mortality between patients with early mortality (16 patients) and surviving patients (153 patients), including comorbidities, HCV and liver characteristics, HCV treatment, and postoperative medical and surgical complications. Patients with early postoperative mortality were more likely to have an associated advanced Child-Pugh classification and comorbidities including peripheral vascular disease, end-stage renal disease, heart failure, and chronic obstructive pulmonary disease. However, both groups had similar 90-day and 1-year medical complication risks including myocardial infarction, stroke, pulmonary embolism, and reoperations for periprosthetic joint infection and mechanical failure. A multivariable regression analysis was performed to identify independent factors associated with early mortality, incorporating all significant variables with p < 0.05 present in the univariate analysis. RESULTS: After accounting for significant variables in the univariate analysis such as peripheral vascular disease, end-stage renal disease, heart failure, chronic obstructive pulmonary disease, and liver fibrosis staging, Child-Pugh Class B or C classification was found to be the sole factor independently associated with increased odds of early (within 2 years) mortality in patients with HCV undergoing elective TJA (adjusted odds ratio 29 [95% confidence interval 5 to 174]; p < 0.001). The risk of early mortality in patients with Child-Pugh Class B or C was 64% (seven of 11) compared with 6% (nine of 158) in patients with Child-Pugh Class A (p < 0.001). CONCLUSION: Patients with HCV and a Child-Pugh Class B or C at the time of elective TJA had substantially increased odds of death, regardless of liver function, cirrhosis, age, Model for End-Stage Liver Disease level, HCV treatment, and viral load status. This is similar to the risk of early mortality observed in patients with chronic liver disease undergoing abdominal and cardiac surgery. Surgeons should avoid these major elective procedures in patients with Child-Pugh Class B or C whenever possible. For patients who feel their arthritic symptoms and pain are unbearable, surgeons need to be clear that the risk of death is considerably elevated. LEVEL OF EVIDENCE: Level III, therapeutic study.
引用
- Cichos KH, Jordan E, Niknam K, et al. Child-Pugh Class B or C Liver Disease Increases the Risk of Early Mortality in Patients With Hepatitis C Undergoing Elective Total Joint Arthroplasty Regardless of Treatment Status. Clin Orthop Relat Res. 2023. PMID: 36961471. doi:10.1097/CORR.0000000000002631
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。